Monopar Therapeutics (NASDAQ:MNPR) filed to sell 882,761 shares of common stock for holders. This prospectus is not an offer to sell. Filing More on Monopar Therapeutics Monopar: Radiopharmaceutical ...
The U.S. Securities and Exchange Commission has sued billionaire Elon Musk, saying he failed to disclose his ownership of ...
Smithfield Foods on Monday made public its paperwork for its New York initial public offering as the maker of Farmland bacon ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback